Compare US Global Jets ETF (JETS) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
US Global Jets ETF vs TransMedics Group Inc — how do they compare? US Global Jets ETF trades at $31.44, while TransMedics Group Inc trades at $86.75 (market cap $3.10B). The key difference: US Global Jets ETF is trading nearer its 52-week high, TransMedics Group Inc nearer its low. Which is the better fit depends on your goals.
| JETS | TMDX | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $33.53 | $150.42 |
52-Week Low | $23.64 | $61.99 |
Market Cap | — | $3.10B |
Enterprise Value | — | $3.49B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
JETS trades at $31.62, up 0.57% with a bullish technical signal from moving averages. The ETF faces mixed sentiment as airline stocks benefit from strong travel demand and falling oil prices, while fuel cost volatility and geopolitical risks create headwinds. Recent news highlights earnings beats from major holdings like JetBlue but also significant fuel price increases affecting industry profitability.
Outlook remains cautiously optimistic with technical strength supporting near-term gains, though fundamental pressures from fuel costs and cyclical exposure warrant monitoring. The ETF offers pure-play airline exposure with diversification benefits, but investors should weigh competitive ETF alternatives with lower volatility and expense ratios.
TransMedics Group (TMDX) trades at $87.02, down 1.57% today, amid mixed signals. The stock shows a bullish technical trend with moving averages supporting upside, but oscillators like RSI indicate overbought conditions near 78. Fundamentally, the company reported record Q2 2026 revenue but missed earnings estimates, with net income margin declining to 22.69% from 31.42% in 2025. Recent news highlights an ongoing investigation into fiduciary duties by Rosen Law Firm, adding uncertainty.
The outlook remains cautiously optimistic with a consensus price target of $99.57, implying 14% upside, supported by strong analyst buy ratings (69%). However, risks include earnings volatility, margin pressure from rising costs, and legal scrutiny. Investors should weigh robust revenue growth against execution risks and elevated valuation multiples like a P/E of 23.15.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About US Global Jets ETF
JETS provides targeted exposure to the global airline industry, including commercial airlines, aircraft manufacturers, and airport operators. It focuses on major U.S. and international carriers like Delta, United, and American Airlines.
Read more on JETS →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
